Regencell Bioscience Stock (NASDAQ: RGC)
|Day Range31.8 - 31.8||52 Wk Range- - 48.29||Open / Close31.8 / 31.8||Float / Outstanding2.7M / 13M|
|Vol / Avg.0.3K / 3.5K||Mkt Cap413.8M||P/E-||50d Avg. Price30.52|
|Div / Yield-||Payout Ratio-||Total Float2.7M||EPS-|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Regencell Bioscience (NASDAQ: RGC) through any online brokerage.
There are no as such competitors for Regencell Bioscience.
The latest price target for Regencell Bioscience (NASDAQ: RGC) was reported by B. Riley Securities on Tuesday, January 2, 2018. The analyst firm set a price target for 0.00 expecting RGC to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Regencell Bioscience (NASDAQ: RGC) is $31.8 last updated September 30, 2022, 4:05 PM UTC.
A quarterly cash dividend of $0.22 per share of Class A Common Stock. The quarterly cash dividend was payable on February 26, 2018 to stockholders of record on February 16, 2018.
Regencell Bioscience’s Q4 earnings are confirmed for Friday, October 14, 2022.
There is no upcoming split for Regencell Bioscience.
Regencell Bioscience is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.